These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 16543633)
21. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department. Ferroni P; Rosa A; Di Franco M; Palmirotta R; Guadagni F; Davì G; Bertazzoni G; Basili S Clin Chim Acta; 2007 Jun; 381(2):151-6. PubMed ID: 17408606 [TBL] [Abstract][Full Text] [Related]
22. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction. Goswami B; Rajappa M; Mallika V; Shukla DK; Kumar S Clin Chim Acta; 2009 Oct; 408(1-2):14-8. PubMed ID: 19576194 [TBL] [Abstract][Full Text] [Related]
23. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. Sato A; Aonuma K; Imanaka-Yoshida K; Yoshida T; Isobe M; Kawase D; Kinoshita N; Yazaki Y; Hiroe M J Am Coll Cardiol; 2006 Jun; 47(11):2319-25. PubMed ID: 16750702 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E; Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173 [TBL] [Abstract][Full Text] [Related]
25. Role of novel mediators of inflammation in left ventricular remodeling in patients with acute myocardial infarction: do they affect the outcome of patients? Oren H; Erbay AR; Balci M; Cehreli S Angiology; 2007; 58(1):45-54. PubMed ID: 17351157 [TBL] [Abstract][Full Text] [Related]
26. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study). Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345 [TBL] [Abstract][Full Text] [Related]
27. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease. Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081 [TBL] [Abstract][Full Text] [Related]
28. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588 [TBL] [Abstract][Full Text] [Related]
29. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years. Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504 [TBL] [Abstract][Full Text] [Related]
30. Establishment of an in-house ELISA and the reference range for serum amyloid A (SAA): complementarity between SAA and C-reactive protein as markers of inflammation. Wu TL; I Chen Tsai ; Chang PY; Tsao KC; Sun CF; Wu LL; Wu JT Clin Chim Acta; 2007 Feb; 376(1-2):72-6. PubMed ID: 16916504 [TBL] [Abstract][Full Text] [Related]
31. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Frasure-Smith N; Lespérance F; Irwin MR; Sauvé C; Lespérance J; Théroux P Biol Psychiatry; 2007 Aug; 62(4):302-8. PubMed ID: 17210140 [TBL] [Abstract][Full Text] [Related]
32. [Kinetics of C-reactive protein release in different forms of acute coronary syndrome]. Sánchez PL; Rodríguez MV; Villacorta E; Albarrán C; Cruz I; Moreiras JM; Martín F; Pabón P; Fernández-Avilés F; Martín-Luengo C Rev Esp Cardiol; 2006 May; 59(5):441-7. PubMed ID: 16750141 [TBL] [Abstract][Full Text] [Related]
33. Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy. Naumnik W; Chyczewska E; Ossolinska M Cancer Invest; 2009 Aug; 27(7):741-6. PubMed ID: 19340656 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score. Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153 [TBL] [Abstract][Full Text] [Related]
35. C-reactive protein and acute coronary syndrome: comparison of conservative and interventional management. Munir TA; Afzal MN J Ayub Med Coll Abbottabad; 2007; 19(2):26-31. PubMed ID: 18183714 [TBL] [Abstract][Full Text] [Related]
36. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. Sajadieh A; Nielsen OW; Rasmussen V; Hein HO; Hansen JF J Intern Med; 2006 Oct; 260(4):377-87. PubMed ID: 16961675 [TBL] [Abstract][Full Text] [Related]
37. Quantitative C reactive protein levels and acute myocardial infarction complications in a Hispanic population: an observational analytical pilot study. Rentas E; Pérez Arzola M; Bredy R Bol Asoc Med P R; 2006; 98(4):284-9. PubMed ID: 19610570 [TBL] [Abstract][Full Text] [Related]
38. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease. Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825 [TBL] [Abstract][Full Text] [Related]
39. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting. Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651 [TBL] [Abstract][Full Text] [Related]